Integrated DNA Technologies acquires Archer™ next generation sequencing research assays to advance actionable scientific discoveries.

Pan-cancer pharmacogenetics: Targeted sequencing panels or exome sequencing?

In this webinar series, Laurentijn walks us through some of the advantages that IDT’s xGen Exome Panel provides over smaller targeted panel solutions for pan-cancer pharmacogenetics studies.

Published on: November 03, 2022

Categories:

Next generation sequencing Methods Whole Exome Sequencing Webinar

*RUO—For research use only. Not for use in diagnostic procedures. Unless otherwise agreed to in writing, IDT does not intend for these products to be used in clinical applications and does not warrant their fitness or suitability for any clinical diagnostic use. Purchaser is solely responsible for all decisions regarding the use of these products and any associated regulatory or legal obligations.